Why the study?
How can cardiovascular magnetic resonance be utilized to assess cardiovascular disease in oncology patients?
How can cardiovascular magnetic resonance be utilized to assess cardiovascular disease in oncology patients?
CMR provides comprehensive assessment of cardiac structure, function, and tissue characterization, making it a key tool in cardio-oncology.
CMR may aid cardio-oncology evaluation; leaves open need for prospective outcome trials.
Patients with or receiving potentially cardiotoxic treatment for cancer are susceptible to developing decrements in left ventricular mass, diastolic function, or systolic function. They may also experience valvular heart disease, pericardial disease, or intracardiac masses. Cardiovascular magnetic resonance may be used to assess cardiac anatomy, structure, and function and to characterize myocardial tissue. This combination of features facilitates the diagnosis and management of disease processes in patients with or those who have survived cancer. This report outlines and describes prior research involving cardiovascular magnetic resonance for assessing cardiovascular disease in patients with or previously having received treatment for cancer.
No takes yet. Share an insight, caveat, or question.
Jordan et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: